Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Syngene's G:BOX XR5 is Being Utilized at the University of Cambridge

Published: Friday, February 01, 2013
Last Updated: Friday, February 01, 2013
Bookmark and Share
To contribute to understanding which genes are involved in remyelination.

Syngene has announced that the G:BOX XR5 imaging system is being used at the University of Cambridge to visualize and analyze DNA as part of a research programme to understand the molecular mechanisms behind why the remyelination process fails in diseases such as Multiple Sclerosis (MS).

Scientists in the Neurosciences Group at the Department of Veterinary Medicine, part of the University of Cambridge are using a G:BOX XR5 system to accurately image gels of fluorescent dye stained PCR products derived from genes involved in the remyelination process.

By studying these genes, the scientists hope to find a means of enhancing the repair of normally non-repairable clinical conditions such as MS.

Dr Chao Zhao Assistant Director of Research, in the Neurosciences Group says: “Our research focuses on the mechanism of remyelination of the central nervous system after demyelination. To do this we are trying to understand the molecular mechanism of why myelin repair fails in diseases such as MS and we use the G:BOX XR5 every day to visualize and sometimes analyze very small amounts of PCR products as part of this research.”

Dr Zhao continued: “We consistently get the results we want with our G:BOX XR5 so we are happy with the system for our DNA analysis work.”

Laura Sullivan, Syngene’s Divisional Manager said: “We are delighted to hear researchers at such a prestigious department in the university are using Syngene technology in this important programme. Their work is testament to the fact that for DNA analysis, the G:BOX XR5 is a totally reliable and sensitive gel documentation system.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Syngene Appoints AlphaMetrix Biotech and LTF Labortechnik in Germany
New distributors will provide access to innovative image analysis systems.
Tuesday, June 23, 2015
Syngene Appoints Talented, New International Sales Manager
To provide client driven support for its high quality image analysis systems.
Saturday, May 30, 2015
Expert Potato Breeder uses SDI’s Syngene Image Analysis System To Help Identify Unknown Varieties
Imaging system is being used at a specialist European potato breeding company, Agrico Research BV in the Netherlands to make it easier to visualise and analyse DNA markers.
Monday, June 24, 2013
Syngene Appoints VWR International as New Canadian Distributor
Companies to provide superior service and support for life scientists in Canada.
Thursday, March 28, 2013
G:BOX Chemi XT Analyser at Major Cancer Research Centre
Developed to detect DNA and proteins associated with tumour generation.
Wednesday, October 27, 2010
Major Molecular Medicine Centre Uses G:BOX iChemi XT Image Analyser
Syngene’s imaging system is used to identify proteins that impact the pathology of muscular dystrophy.
Monday, October 25, 2010
100th Syngene Image Analyzer in Singapore
The new G:BOX system to be used alongside the 10 other Syngene analyzers purchased by the University since 2001.
Friday, July 16, 2010
University of York uses G:BOX Imaging System
Syngene’s imaging being used as fast and cost-effective system of assessing protein expression.
Tuesday, June 01, 2010
Versatile Dyversity System at Leading European Cancer Research Centre
UK Cambridge Research Institute uses Dyversity to accelerate the pace of research on proteins and DNA associated with a variety of different cancers.
Friday, May 07, 2010
Versatile Dyversity System at Leading European Cancer Research Centre Rapidly Analyses Fluorescent and Chemiluminescent Proteins with Ease
Syngene, a world-leading manufacturer of image analysis sol- utions, is pleased to announce its Dyversity multi-application image analyser is being used by scientists in The Cancer Research UK Cambridge Research Institute (CRI) at the University of Cambridge, one of Europe’s major cancer research hubs, to accelerate the pace of research on proteins and DNA associated with a variety of different cancers.
Thursday, May 06, 2010
Einstein Researchers Uses Dyversity Image Analysis System for Proteins Detection
Syngene’s 2D gel imaging system helps to detect proteins associated with longer human life span.
Friday, June 19, 2009
G:BOX Chemiluminescence Imager is used at Edinburgh Napier University
Napier Researchers are using the G:BOX chemiluminescence imaging system to determine the pre-clinical potential of anti-cancer compounds.
Monday, May 11, 2009
Syngene Partners with Sapient Discovery to Expand Integrated Drug Discovery Offerings
Companies to develop a platform with one stop shop for structure-guided discovery, chemistry, biology and structural biology capabilities.
Wednesday, February 04, 2009
Image Analyser used at Major US Pain Research Centre Improves Accuracy of Detecting Proteins Associated with Spinal Cord Injury
Syngene has announced that the Dartmouth-Hitchcock Medical Centre (DHMC), is significantly improving detection of proteins associated with spinal cord injuries, using a G:BOX Chemi HR16.
Thursday, May 22, 2008
Dymension 2D Gel Analysis Software used at Specialist Institute
Syngene’s software is being used to identify proteins induced by an anti-addictive compound.
Friday, February 22, 2008
Scientific News
Liquid Biopsies: Utilization of Circulating Biomarkers for Minimally Invasive Diagnostics Development
Market Trends in Biofluid-based Liquid Biopsies: Deploying Circulating Biomarkers in the Clinic. Enal Razvi, Ph.D., Managing Director, Select Biosciences, Inc.
Lab-on-a-Chip Offers Promise for TB and Asthma Patients
A device to mix liquids using ultrasonics is the first and most difficult component in a miniaturized system for low-cost analysis of sputum from patients with pulmonary diseases such as tuberculosis and asthma.
Intracellular Microlasers Could Allow Precise Labeling of up to a Trillion Individual Cells
MGH investigators have induced structures incorporated within individual cells to produce laser light at wavelengths that differ based on the size, shape and composition of each microlaser, allowing precise labeling of individual cells.
Real-Time Imaging of Lung Lesions During Surgery
Targeted molecular agents cause lung adenocarcinomas to fluoresce during surgery, according to pilot report.
Watching a Tumour Grow in Real-Time
Researchers from the University of Freiburg have gained new insight into the phases of breast cancer growth.
Protein Related to Long Term Traumatic Brain Injury Complications Discovered
NIH-study shows protein found at higher levels in military members who have suffered multiple TBIs.
Childhood Cancer Cells Drain Immune System’s Batteries
Cancer cells in neuroblastoma contain a molecule that breaks down a key energy source for the body’s immune cells, leaving them too physically drained to fight the disease.
Urine Proteins Point to Early-Stage Pancreatic Cancer
A combination of three proteins found at high levels in urine can accurately detect early-stage pancreatic cancer, researchers at the BCI have shown.
Researcher Discovers Trigger of Deadly Melanoma
New research sheds light on the precise trigger that causes melanoma cancer cells to transform from non-invasive cells to invasive killer agents, pinpointing the precise place in the process where "traveling" cancer turns lethal.
New Vaccine For Chlamydia to Use Synthetic Biology
Prokarium Ltd, a biotechnology company developing transformational oral vaccines, have announced new funding from SynbiCITE, the UK’s Innovation and Knowledge Centre for Synthetic Biology.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!